Compare Indo Komoditi Korpora Tbk. (INCF) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indo Komoditi Korpora Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Indo Komoditi Korpora Tbk. trades at Rp50 (market cap 71.92B), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Organon Pharma Indonesia Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| INCF | SCPI | |
|---|---|---|
Market Cap | 71.92B | 104.4B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Indo Komoditi Korpora Tbk.
PT Indo Komoditi Korpora Tbk (the Company) and its subsidiary (together referred as the "Group"), established in the Republic of Indonesia based on deed of establishment No. 125 dated February 23rd, 1982, made in the presence of Frederik Alexander Tumbuan, S.H., Notary in Jakarta, which the Company was originally named PT Indo Alaya Leasing Corporation.
Read more on INCF →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
